10-Q: Cardiff Lexington Corporation Reports Second Quarter 2024 Results, Revenue Declines Amidst Strategic Shifts

Cardiff Lexington Corporation's Q2 2024 results show a decrease in revenue and a net loss, influenced by a shift in service mix and increased operating expenses.

Summary

• Cardiff Lexington Corporation reported a net loss of $174,447 for the three months ended June 30, 2024, compared to a net income of $816,078 for the same period in 2023.
• Revenue decreased by 30.72% to $2,330,964 in Q2 2024, down from $3,364,506 in Q2 2023, primarily due to a change in the mix of services provided.
• The company's cost of sales decreased by 26.69% to $793,010, while operating expenses increased significantly, driven by a 227.72% rise in selling, general, and administrative expenses to $1,736,933.
• For the six months ended June 30, 2024, the company reported a net loss of $457,551, compared to a net income of $800,087 for the same period in 2023.
• Revenue for the first half of 2024 decreased by 17.76% to $4,992,930, while cost of sales decreased by 14.56% to $1,741,164.
• Selling, general, and administrative expenses for the first half of 2024 increased by 92.90% to $2,928,163, and the company recorded a bad debt expense of $1,242,017.
• The company had a cash balance of $3,196,795 as of June 30, 2024.
• The company has a 99% collection rate based on net settlements recorded to its accounts receivable and revenue.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with declining revenue, increased expenses, and a net loss. The company's reliance on future capital raises and the identified material weaknesses in internal controls add to the negative sentiment.

Positives

• Cost of sales decreased by 26.69% in Q2 2024 and 14.56% for the first half of 2024.
• The company achieved a gain on debt refinance and forgiveness of $78,834 in Q2 2024.
• The company has a 99% collection rate based on net settlements recorded to its accounts receivable and revenue.
• The company has a line of credit with a maximum advance amount of $11,000,000.

Negatives

• The company experienced a significant decrease in revenue in both Q2 2024 and the first half of 2024.
• Selling, general, and administrative expenses increased substantially in both Q2 2024 and the first half of 2024.
• The company reported a net loss for both Q2 2024 and the first half of 2024.
• The company's bad debt expense increased significantly in the first half of 2024.
• The company's gross margin decreased from 67.85% in Q2 2023 to 65.98% in Q2 2024.

Risks

• The company's ability to continue as a going concern is dependent on additional cash infusions.
• The company may need to raise additional capital through debt or equity transactions, which could result in dilution or increased debt service obligations.
• The company's efforts to accelerate cash collections have resulted in lower than normal settlements of accounts receivable.
• The company's internal controls over financial reporting were deemed ineffective as of June 30, 2024, due to material weaknesses.
• The company is subject to inherent uncertainties in litigation, which could harm the business.

Future Outlook

The company believes that current working capital and expected additional financing should be sufficient to fund operations for at least one year, but additional funds are required for continued operations and acquisitions. The company intends to raise capital primarily through equity and debt financings.

Management Comments

• Management is in continuous discussions with prospective investors and believes the raising of capital will allow the Company to fund its cash flow shortfalls and pursue new acquisitions.
• Management monitors key metrics primarily revenues and net income from operations.
• Management has invested years working to develop a new and exciting housing development in Salmon, Idaho and plans to enter into a joint venture agreement with a developer for this planned concept development.

Industry Context

The company operates primarily in the healthcare industry, focusing on orthopedic services and related care. The company also has a real estate segment. The healthcare industry is subject to various regulations and market conditions that can impact the company's performance. The company's focus on plaintiff-related care and EMC assessments positions it within a specific niche of the healthcare market.

Comparison to Industry Standards

• The company's revenue decline contrasts with the general trend of growth in the healthcare sector, particularly in specialized areas like orthopedics.
• The increase in selling, general, and administrative expenses is higher than the industry average, indicating potential inefficiencies or strategic investments.
• The company's reliance on a 99% collection rate for accounts receivable is higher than the industry average, which typically ranges from 80% to 95%, indicating a unique business model.
• The company's use of letters of protection is a common practice in the personal injury medical field, but the company's specific collection rate and timeline are unique.
• The company's financial performance is not directly comparable to larger, more established healthcare providers due to its acquisition-focused business model and smaller scale of operations.
• The company's real estate segment is not directly comparable to other real estate companies due to its specific focus on land development in a particular geographic area.

Management Changes

Related Party Transactions

• The company has amounts due to previous owners of Edge View, who are current managers.
• The company obtained short-term advances from the Chairman of the Board that are non-interest bearing and due on demand.

Stakeholder Impact

• Shareholders may be concerned about the company's declining revenue and net loss.
• Employees may be affected by potential cost reductions or changes in operations.
• Customers may experience changes in service offerings or pricing.
• Creditors may be concerned about the company's ability to repay its debts.
• Suppliers may be affected by changes in the company's purchasing patterns.

Next Steps

• The company plans to implement proper documentation procedures for key functional areas, control objectives and workflows.
• The company intends to complete the remediation of the material weaknesses in internal control over financial reporting.
• The company plans to reinforce effective compensating controls to improve the design of the current process with limited human resources.
• The company plans to enter into a joint venture agreement with a developer for its planned housing development in Salmon, Idaho.

Key Dates

Keywords

healthcare, orthopedic, revenue, net loss, convertible notes, preferred stock, operating expenses, accounts receivable, debt, financial results, settlement agreement, line of credit